Invited oral presentation includes in vivo proof-of-concept data for AI-identified targeted therapies to be incorporated into ADCs to treat early-stage lung adenocarcinoma. CAMBRIDGE, MA / ACCESS ...

Turbine's virtual lab enables in silico experimentation using a vast library of cell models, patient-derived samples and virtual patients. By computationally predicting therapy effects, drug ...

Anteris Technologies Global Corp.’s AVR share price has surged by 12.25%, which has investors questioning if this is right time to sell.

AB Science SA (Euronext - FR0010557264 - AB) announces today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the ...

The FFPE-compatible service also includes a unique RNA-seq workflow optimized for highly fragmented samples, enabling ...

The AERIAL trial will assess LEU011, which has MHRA Innovation Passport status, for solid tumors, a challenging area compared ...

Explore the differences between turmeric and curcumin, their unique health benefits, and how to determine which supplement ...

A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding ...

PNKP TechnologyShown in Past Study to Increase Survival Rate in Colorectal Cancer Bearing Mice. VANCOUVER, BC / / April 17, 2025 / Onco-Innovations Limited (CSE:ON ...

Powered Research, a leading preclinical CRO specializing in non-GLP models, has launched its oncology models and research services tailored to meet the unique needs of life science R&D companies. This ...

The Europe dental bone grafts and substitutes market is experiencing robust growth, with projections indicating a rise from a market value of US$ 271.07 million in 2023 to US$ 494.18 million by 2032.